Premium
Response to Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
Author(s) -
Su TungHung,
Kao JiaHorng
Publication year - 2017
Publication title -
liver international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.873
H-Index - 110
eISSN - 1478-3231
pISSN - 1478-3223
DOI - 10.1111/liv.13315
Subject(s) - hepatology , medicine , entecavir , hepatocellular carcinoma , family medicine , hepatitis b , gastroenterology , viral hepatitis , chronic hepatitis , immunology , lamivudine , virus
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom